Abstract:BackgroundAlzheimer’s disease (AD) neuropathology reveals progressive microstructural alterations of cortical architecture. Recent studies reported intriguing biphasic trajectories of cortical structural changes in the early stages of Alzheimer’s disease (AD), comprising decreased mean diffusivity (MD) and increased cortical thickness in cognitively normal amyloid-positive individuals, ahead of increases and decreases, respectively, in subsequent disease stages.ObjectiveTo better understand the cytoarchitectural correlates of these observations, we assessed novel cortical diffusion tensor imaging (DTI) metrics that are correlated with disruption of cortical minicolumns and protein deposition.DesignCross-sectional and longitudinal analysis of whole brain and temporal lobe cortical diffusivity measures. Investigation of associations between baseline cortical diffusivity values and 24-month longitudinal structural-MRI changes. Investigations of the relationships between cortical diffusivity measures and biomarkers of neuroinflammation.SettingAlzheimer’s Disease Neuroimaging Initiative (ADNI).ParticipantsTwenty-four amyloid-negative controls (CN-), 28 amyloid-positive controls (CN+), 46 amyloid-positive subjects with mild cognitive impairment (MCI+) and 22 amyloid-positive subjects with AD were included.Measurements3DT1 and DTI scans at baseline and approximately 24-month follow-up were used to calculate cortical MD and three novel cortical diffusivity measures: the angle between the radial minicolumnar axis and the principal diffusion direction (AngleR); the diffusion components perpendicular to the minicolumns (PerpPD+), and the principal diffusion component parallel with the minicolumns (ParlPD). Cortical macrostructural measurements (cortical volume fraction and cortical thickness), were used to test the hypothesis that baseline cortical diffusivity values can predict change in structural MRI outcomes over approximately 24 months. CSF soluble TREM2 and progranulin (PGRN) concentrations were used to investigate associations with microglial activity and potentially other aspects of neuroinflammation.ResultsCortical diffusivity metrics revealed a dependence on disease stage, with AngleR and PerpPD+ displaying biphasic relationships and ParlPD a monotonic relationship with clinical severity. The novel metrics were able to differentiate between Amyloid+ and Amyloid- controls (AngleR) and to differentiate among disease stages along the AD continuum (PerpPD+). Linear regression revealed significant associations between baseline cortical diffusivity values and subsequent 24-month longitudinal structural-MRI changes. AngleR values were significantly associated with CSF sTREM2 and PGRN concentrations.ConclusionsCortical diffusivity parameters reflecting minicolumnar organization and neuroinflammation may provide a sensitive and biologically interpretable measurement of cortex quality and microstructure across the AD continuum.

Medial temporal lobe gray matter microstructure in preclinical Alzheimer's disease

DIFFERENTIAL GREY AND WHITE MATTER MICROSTRUCTURAL ABNORMALITIES IN EARLY AND LATE-ONSET ALZHEIMER’S DISEASE AND MILD COGNITIVE IMPAIRMENT

Characterization of Local White Matter Microstructural Alterations in Alzheimer’s Disease: A Reproducible Study

Assessment of Gray Matter Microstructure and Synaptic Density in Alzheimer's Disease: A Multimodal Imaging Study With DTI and SV2A PET

Early Cortical Microstructural Changes in Aging Are Linked to Vulnerability to Alzheimer's Disease Pathology

Layer‐specific Microstructural Patterns of Anterior Hippocampus in Alzheimer's Disease with Ex Vivo Diffusion MRI at 14.1 T

Clinical utility of diffusion MRI‐derived measures of cortical microstructure in a real‐world memory clinic setting

Brain structural indicators of β-amyloid neuropathology

Relationship Between Longitudinal, Structural Magnetic Resonance Imaging and [18f]fluorodeoxyglucose Positron Emission Tomography Data From The Alzheimer'S Disease Neuroimaging Initiative Study

P4‐053: Relationship Between Longitudinal, Structural Magnetic Resonance Imaging and [18f]fluorodeoxyglucose Positron Emission Tomography Data from the Alzheimer'S Disease Neuroimaging Initiative Study

Discriminative Analysis of Early-Stage Alzheimer’s Disease and Normal Aging with Automatic Segmentation Technique in Subcortical Gray Matter Structures: a Multicenter in Vivo MRI Volumetric and DTI Study

P-020: Regional Gray Matter Reductions in Alzheimer’s Dementia and Amnestic Mild Cognitive Impairment: Preliminary Findings from the Alzheimer’s Disease Neuroimaging Initiative Using Voxel-Based Morphometry

The role of diffusion tensor imaging in detecting microstructural changes in prodromal Alzheimer's disease

In Vivo Detection of Microstructural Correlates of Brain Pathology in Preclinical and Early Alzheimer Disease with Magnetic Resonance Imaging.

Medial temporal lobe (MTL) – default‐mode network (DMN) functional connectivity disruption in the early stages of the progression of Alzheimer’s disease in a multimodal ADNI3 MP‐RAGE and EPI‐BOLD Advanced cohort

Differential microstructural and morphological abnormalities in mild cognitive impairment and Alzheimer's disease: Evidence from cortical and deep gray matter

IMAGING MICROSCOPIC NEUROPATHOLOGY OF ALZHEIMER’S DISEASE USING MRI: FROM MODEL SYSTEMS TO HUMAN IN VIVO

In Vivo Detection of Changes Related to Cortical Columnar Organization and Neuroinflammation Across the AD Continuum

Diffusion weighted magnetic resonance spectroscopy revealed neuronal specific microstructural alterations in Alzheimer's disease

IC–P–025: Regional Network Pattern of MRI Gray Matter Volume in Alzheimer's Dementia

Early Alzheimer's disease neuropathology detected by proton MR spectroscopy.